Evolus EOLS
NASDAQ EOLS
$7.14 -0.55 (-7.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evolus (EOLS) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Evolus (EOLS) posted Return on Capital Employed [ROCE] of -13.77% for Q2 2026, up 13.67 percentage points from -27.44% a year earlier and up 1.91 percentage points from the prior quarter.

Analysis

Evolus (EOLS) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Evolus' Return on Capital Employed [ROCE] came in at -21.22%, up 2.06 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three consecutive years, with a five-year change of +322.70 percentage points (FY2020 to FY2025).
  • In prior years, Evolus' Return on Capital Employed [ROCE] was -23.28% in FY2024 (+13.14 pp), -36.42% in FY2023 (+1.74 pp), -38.15% in FY2022 (-12.87 pp) and -25.29% in FY2021 (+318.63 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2018.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of +6.83 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2021, with a gain of 450.88 percentage points; the weakest was Q3 2021, with a drop of 56.10 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -15.68% (Q1 2026), -22.20% (Q4 2025) and -24.94% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Evolus 471.34 Mn 279.03 Mn 57.18 Mn -13.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.77%
Mar 31, 2026 -15.68%
Dec 31, 2025 -22.20%
Sep 30, 2025 -24.94%
Jun 30, 2025 -27.44%
Mar 31, 2025 -24.39%
Dec 31, 2024 -20.47%
Sep 30, 2024 -23.84%
Jun 30, 2024 -22.01%
Mar 31, 2024 -28.68%
Dec 31, 2023 -37.82%
Sep 30, 2023 -42.72%
Jun 30, 2023 -45.18%
Mar 31, 2023 -48.21%
Dec 31, 2022 -47.05%
Sep 30, 2022 -48.30%
Jun 30, 2022 -45.01%
Mar 31, 2022 -34.22%
Dec 31, 2021 -24.85%
Sep 30, 2021 -86.02%
API Access

Evolus Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEY